Fontanet, A <br/><br/>
Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisal.  [electronic resource] 

 -  Bone marrow transplantation  Sep 2011 
 - 1272-3 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>1476-5365 
<br/><br/><label>Standard No.: </label>10.1038/bmt.2010.285  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Anti-Infective Agents--adverse effects<br/>Blood Platelets--physiology<br/>Case-Control Studies<br/>Female<br/>Hematologic Diseases--blood<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Male<br/>Middle Aged<br/>Neutrophils--physiology<br/>Trimethoprim, Sulfamethoxazole Drug Combination--adverse effects<br/>Young Adult